ERDANAT 3MG TABLET

Form: Tablets

Pack Size: 28 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹12000.00

NATCO PHARMA LTD (ONCOLOGY DIV): Erdanat 3MG Tablet, 28 tablets, salt erdafitinib 3mg. Its MRP stays at Rs 12,000 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 9,142.86. Group: FGFR inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: needs a confirmed FGFR test; phosphate checks guide dose changes. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.